Discover
IMVT
Immunovant, Inc.
39.70
1 x 39.66
1 x 39.71
bid
ask
-
0.19
0.46%
12:36 PM
timesize
| Ytd | 56.20% | |
| 1y | 169.00% |
38.99
day range
39.88
14.47
52 week range
41.23
| Open | 39.84 | Prev Close | 39.89 | Low | 38.99 | High | 39.88 | Mkt Cap | 8.20B |
| Vol | 541.45K | Avg Vol | 1.70M | EPS | -2.82 | P/E | -14.09 | Forward P/E | -16.07 |
| Beta | 0.77 | Short Ratio | 11.24 | Inst. Own | 54.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 37.21 | 200-d Avg | 28.70 | 1yr Est | 48.33 |
| Income Statement | |||
| Operating Expenses | 160.32M | ||
| Research and Development Expense | 142.63M | ||
| Selling, General and Administrative Expense | 17.69M | ||
| Operating Income | -160.32M | ||
| Net Income | -153.22M | ||
| Net Income Common Stock | -153.22M | ||
| Net Income Common Stock (USD) | -153.22M | ||
| Consolidated Income | -153.22M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -153.22M | ||
| Earning Before Interest & Taxes (USD) | -153.22M | ||
| Weighted Average Shares | 205.55M | ||
| Weighted Average Shares Diluted | 205.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 797.80M | ||
| Cash and Equivalents (USD) | 797.80M | ||
| Trade and Non-Trade Receivables | 697.00K | ||
| Current Assets | 851.18M | ||
| Property, Plant & Equipment Net | 351.00K | ||
| Total Assets | 852.49M | ||
| Current Liabilities | 117.10M | ||
| Total Liabilities | 117.10M | ||
| Accumulated Retained Earnings (Deficit) | -1.90B | ||
| Accumulated Other Comprehensive Income | 725.00K | ||
| Shareholders Equity | 735.39M | ||
| Shareholders Equity (USD) | 735.39M | ||
| Assets Non-Current | 1.31M | ||
| Trade and Non-Trade Payables | 10.14M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 119.00K | ||
| Net Cash Flow from Financing | 20.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -104.31M | ||
| Issuance (Purchase) of Equity Shares | 20.10M | ||
| Net Cash Flow from Operations | -124.40M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 13.77M | ||